Stock Report

Divi's Laboratories Ltd reports consolidated PAT of Rs. 519.59 crore in Q2 FY20-21



Posted On : 2020-11-07 13:41:49( TIMEZONE : IST )

DIVI's LABORATORIES LTD. has reported financial results for the period ended September 30, 2020.

Financial Results (Q2 FY20-21) - QoQ Comparison

The company has reported total income of Rs.1762.94 crores during the period ended September 30, 2020 as compared to Rs.1747.80 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.519.59 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.492.06 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.19.57 for the period ended September 30, 2020 as compared to Rs.18.54 for the period ended June 30, 2020.

FinancialsQ2 FY20-21Q1 FY20-21% Change
Total Income₹ 1762.94 crs₹ 1747.80 crsUp Tick 0.87%
Net Profit₹ 519.59 crs₹ 492.06 crsUp Tick 5.59%
EPS₹ 19.57₹ 18.54Up Tick 5.56%

Financial Results (Q2 FY20-21) - YoY Comparison

The company has reported total income of Rs.1762.94 crores during the period ended September 30, 2020 as compared to Rs.1492.60 crores during the period ended September 30, 2019.

The company has posted net profit / (loss) of Rs.519.59 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.356.78 crores for the period ended September 30, 2019.

The company has reported EPS of Rs.19.57 for the period ended September 30, 2020 as compared to Rs.13.44 for the period ended September 30, 2019.

FinancialsQ2 FY20-21Q2 FY19-20% Change
Total Income₹ 1762.94 crs₹ 1492.60 crsUp Tick 18.11%
Net Profit₹ 519.59 crs₹ 356.78 crsUp Tick 45.63%
EPS₹ 19.57₹ 13.44Up Tick 45.61%

Financial Results (6 months ended FY 20-21) - YoY Comparison

The company has reported total income of Rs.3505.93 crores during the 6 months period ended September 30, 2020 as compared to Rs.2679.68 crores during the 6 months period ended September 30, 2019.

The company has posted net profit / (loss) of Rs.1011.65 crores for the 6 months period ended September 30, 2020 as against net profit / (loss) of Rs.629.22 crores for the 6 months period ended September 30, 2019.

The company has reported EPS of Rs.38.11 for the 6 months period ended September 30, 2020 as compared to Rs.23.70 for the 6 months period ended September 30, 2019.

FinancialsHalf-Year Ended FY20-21Half-Year Ended FY19-20% Change
Total Income₹ 3505.93 crs₹ 2679.68 crsUp Tick 30.83%
Net Profit₹ 1011.65 crs₹ 629.22 crsUp Tick 60.78%
EPS₹ 38.11₹23.70Up Tick 60.8%

We have capitalized assets of Rs.615 crores during the quarter and the total capitalization done during the half-year amounted to Rs.830 crores. We expect to complete the ongoing capex programs by end of the financial year.

Apart from the existing capex programs, the company is taking up a new capex for an aggregate amount of Rs.400 crores for meeting new business opportunities in the custom synthesis projects; and needed to be completed on fast track.

Shares of DIVI's LABORATORIES LTD. was last trading in BSE at Rs.3237.7 as compared to the previous close of Rs. 3208.3. The total number of shares traded during the day was 50537 in over 2538 trades.

The stock hit an intraday high of Rs. 3265 and intraday low of 3188.5. The net turnover during the day was Rs. 162676996.

Source : Equity Bulls

Keywords